Literature DB >> 17891462

Presence of residual beta cells and co-existing islet autoimmunity in the NOD mouse during longstanding diabetes: a combined histochemical and immunohistochemical study.

Shiva Reddy1, Ryan Chau Chia Chai, Jessica Astrid Rodrigues, Tzu-Hsuan Hsu, Elizabeth Robinson.   

Abstract

During type 1 diabetes, most beta cells die by immune processes. However, the precise fate and characteristics of beta cells and islet autoimmunity after onset are unclear. Here, the extent of beta cell survival was determined in the non-obese diabetic (NOD) mouse during increasing duration of disease and correlated with insulitis. Pancreata from female NOD mice at diagnosis and at 1, 2, 3 and 4 weeks thereafter were analysed immunohistochemically for insulin, glucagon and somatostatin cells and glucose transporter-2 (glut2) and correlated with the degree of insulitis and islet immune cell phenotypes. Insulitis, although variable, persisted after diabetes and declined with increasing duration of disease. During this period, beta cells also declined sharply whereas glucagon and somatostatin cells increased, with occasional islet cells co-expressing insulin and glucagon. Glut2 was absent in insulin-containing cells from 1 week onwards. CD4 and CD8 T cells and macrophages persisted until 4 weeks, in islets with residual beta cells or extensive insulitis. We conclude that after diabetes onset, some beta cells survive for extended periods, with continuing autoimmunity and expansion of glucagon and somatostatin cells. The absence of glut2 in several insulin-positive cells suggests that some beta cells may be unresponsive to glucose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891462     DOI: 10.1007/s10735-007-9122-5

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  29 in total

Review 1.  Islet growth and development in the adult.

Authors:  S Bonner-Weir
Journal:  J Mol Endocrinol       Date:  2000-06       Impact factor: 5.098

Review 2.  Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter.

Authors:  B Thorens
Journal:  Int Rev Cytol       Date:  1992

3.  Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study.

Authors:  Shiva Reddy; Praneeti Pathipati; Yan Bai; Elizabeth Robinson; Jacqueline M Ross
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

4.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

5.  Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.

Authors:  W Gepts; J De Mey
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

6.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

7.  Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse.

Authors:  Y Kano; T Kanatsuna; N Nakamura; Y Kitagawa; H Mori; S Kajiyama; K Nakano; M Kondo
Journal:  Diabetes       Date:  1986-04       Impact factor: 9.461

8.  Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse.

Authors:  S Reddy; N J Bibby; R B Elliott
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

9.  Cellular composition of the human diabetic pancreas.

Authors:  J Rahier; R M Goebbels; J C Henquin
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

10.  Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus.

Authors:  B Charlton; A Bacelj; R M Slattery; T E Mandel
Journal:  Diabetes       Date:  1989-04       Impact factor: 9.461

View more
  7 in total

1.  Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.

Authors:  Anne Jörns; Tanja Arndt; Andreas Meyer zu Vilsendorf; Jürgen Klempnauer; Dirk Wedekind; Hans-Jürgen Hedrich; Lorella Marselli; Piero Marchetti; Nagakatsu Harada; Yutaka Nakaya; Gen-Sheng Wang; Fraser W Scott; Conny Gysemans; Chantal Mathieu; Sigurd Lenzen
Journal:  Diabetologia       Date:  2013-12-06       Impact factor: 10.122

2.  A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.

Authors:  T Pearson; L D Shultz; J Lief; L Burzenski; B Gott; T Chase; O Foreman; A A Rossini; R Bottino; M Trucco; D L Greiner
Journal:  Diabetologia       Date:  2008-06-19       Impact factor: 10.122

3.  Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.

Authors:  Christian W Grant; Shane K Duclos; Catherine M Moran-Paul; Barak Yahalom; Rebecca S Tirabassi; Guillermo Arreaza-Rubin; Lisa M Spain; Dennis L Guberski
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

4.  Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis.

Authors:  G J Taborsky; Q Mei; D J Hackney; D P Figlewicz; R LeBoeuf; T O Mundinger
Journal:  Diabetologia       Date:  2009-10-02       Impact factor: 10.122

5.  Exercise Training but not Curcumin Supplementation Decreases Immune Cell Infiltration in the Pancreatic Islets of a Genetically Susceptible Model of Type 1 Diabetes.

Authors:  Leandro Kansuke Oharomari; Camila de Moraes; Anderson Marliere Navarro
Journal:  Sports Med Open       Date:  2017-04-04

6.  Pancreatic alpha-cell mass in the early-onset and advanced stage of a mouse model of experimental autoimmune diabetes.

Authors:  Eva Bru-Tari; Nadia Cobo-Vuilleumier; Paloma Alonso-Magdalena; Reinaldo S Dos Santos; Laura Marroqui; Angel Nadal; Benoit R Gauthier; Ivan Quesada
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

7.  Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes.

Authors:  R Piran; S-H Lee; C-R Li; A Charbono; L M Bradley; F Levine
Journal:  Cell Death Dis       Date:  2014-07-31       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.